PharmacoEconomics : Impact Factor & More
eISSN: 1179-2027pISSN: 1170-7690
Share this on:
Aims and Scope of PharmacoEconomics
PharmacoEconomics is a peer-reviewed medical journal published by Adis International (Springer Nature) that covers the fields of health economics, pharmacoeconomics, and quality-of-life assessment.
Key Metrics
CiteScore 
7.5
Eigenfactor
0.005 - 0.01
H-Index
112
Impact Factor
< 5
SJR
Q1Pharmacology
SNIP
1.85
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on PharmacoEconomics
PharmacoEconomics Journal Specifications
| Overview | |
| Publisher | ADIS INT LTD |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 1992 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in PharmacoEconomics ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in PharmacoEconomics
Flexibility in the Modelling of Comparative Effectiveness in the Absence of Head-to-Head Comparisons in the NICE Single Technology Appraisal of Fenfluramine for Treating Seizures Associated with Lennox-Gastaut Syndrome: An External Assessment Group Perspective.
- 1 Jun 2026
- PharmacoEconomics
Chronic Kidney Disease (CKD): Systematic Review of the Cost Effectiveness of SGLT2 Inhibitors and Other Novel Nephroprotective Drugs.
- 1 Jun 2026
- PharmacoEconomics
From Paper to Platform: Updating the Dutch Costing Manual and Launching a Web Application.
- 1 Jun 2026
- PharmacoEconomics
Public Health Impact and Cost-Effectiveness of Revising the Adolescent Meningococcal Vaccine Schedule in the United States.
- 1 Jun 2026
- PharmacoEconomics
Cost-Effectiveness of Immunising Interventions to Reduce Respiratory Syncytial Virus Disease Burden in Infants in Australia.
- 1 Jun 2026
- PharmacoEconomics
Component Clinical and Cost Outcomes Complementing Value of Information: Case Study of a Tuberculosis Diagnostics Clinical Trial.
- 1 Jun 2026
- PharmacoEconomics
Flexibility in the Modelling of Comparative Effectiveness in the Absence of Head-to-Head Comparisons in the NICE Single Technology Appraisal of Fenfluramine for Treating Seizures Associated with Lennox-Gastaut Syndrome: An External Assessment Group Perspective.
- 1 Jun 2026
- PharmacoEconomics
Chronic Kidney Disease (CKD): Systematic Review of the Cost Effectiveness of SGLT2 Inhibitors and Other Novel Nephroprotective Drugs.
- 1 Jun 2026
- PharmacoEconomics
From Paper to Platform: Updating the Dutch Costing Manual and Launching a Web Application.
- 1 Jun 2026
- PharmacoEconomics
Public Health Impact and Cost-Effectiveness of Revising the Adolescent Meningococcal Vaccine Schedule in the United States.
- 1 Jun 2026
- PharmacoEconomics
Cost-Effectiveness of Immunising Interventions to Reduce Respiratory Syncytial Virus Disease Burden in Infants in Australia.
- 1 Jun 2026
- PharmacoEconomics
Component Clinical and Cost Outcomes Complementing Value of Information: Case Study of a Tuberculosis Diagnostics Clinical Trial.
- 1 Jun 2026
- PharmacoEconomics
FAQs on PharmacoEconomics
How long has PharmacoEconomics been actively publishing? 
What is the publishing frequency of PharmacoEconomics?
How many articles did PharmacoEconomics publish last year?
What is the eISSN & pISSN for PharmacoEconomics?
What is Citescore for PharmacoEconomics?
What is the H Index for PharmacoEconomics ?
What is SNIP score for PharmacoEconomics?
What is the SJR for PharmacoEconomics?
Who is the publisher of PharmacoEconomics?
